Angiotensin II antagonist also protects the kidneys. 2 dialysis-free years for diabetics
MMW Fortschritte der Medizin 143(43): 50
2001
ISSN/ISBN: 1438-3276 PMID: 11715881 Document Number: 535608
Document emailed within 1 workday
Related Documents
Wong, P.C.; Timmermans, P.B. 1991: Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753 Journal of Pharmacology and Experimental Therapeutics 258(1): 49-57Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Kono, T.; Ikeda, F.; Oseko, F.; Imura, H.; Endo, J. 1978: Angiotensin i converting enzyme inhibitor and angiotensin Ii antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3613-3620
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Philips, J.C.; Weekers, L.; Scheen, A.J. 2001: Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy Revue Medicale de Liege 56(2): 126-128
Janković, N.; Orsanić-Brcić, D.; Pavlović, D.; Varlaj-Knobloch, V.; Altabas, K. 2003: Adequacy of dialysis at the Department of Nephrology and Dialysis of the Sveti Duh General Hospital in Zagreb and the Dialysis Outcomes Quality Initiative (DOQI) guidelines--comparison of the years 1998 and 2002 Acta medica Croatica: casopis Hravatske akademije medicinskih znanosti 57(1): 57-60
Bruna, J.; Brunová, E.; Sehr, A.; Vondra, K. 1985: Changes in the size of the pancreas and kidneys in type I diabetics detected by computer tomography Ceskoslovenska Radiologie 39(1): 9-13
Sakio, H.; Oode, H.; Taneyama, C.; Mita, H.; Usui, Y.; Nagayama, T.; Okuda, C. 1985: The effect of angiotensin II antagonist on hypoxemia Masui. Japanese Journal of Anesthesiology 34(7): 973-977
Mundo-Sagardía, J.; Altieri, P.; Banch, H.; González, R.; Escobales, N.; Crespo, M.; Rodríguez-Orengo, J.; Cardona, F.; Torrado, J. 2003: Role of endothelin i and angiotensin Ii in type 2 diabetics with coronary disease Boletin de la Asociacion Medica de Puerto Rico 95(5): 45-50
Landman, L. 1985: The makings of a new contraceptive. An effective, safe, reversible implant protects for five years Rf 6(6): 9-10
Landman, L. 1985: The makings of a new contraceptive. An effective, safe, reversible implant protects for five years Rf 6(6): 9-10
Ramalho, L.N.Z.; Ramalho, F.S.; Zucoloto, Sérgio.; Castro-e-Silva Júnior, O.; Corrêa, F.M.A.; Elias Júnior, J.; Magalhães, Jé.F.G. 2002: Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis Hepato-Gastroenterology 49(48): 1499-1502
Colletti, A.E.; Krieter, P.A. 1994: Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys Drug metabolism and disposition: the biological fate of chemicals 22(2): 183-188
Stearns, R.A.; Doss, G.A.; Miller, R.R.; Chiu, S.H. 1991: Synthesis and identification of a novel tetrazole metabolite of the angiotensin Ii receptor antagonist DuP 753 Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(6): 1160-1162
Haefliger, J.A.; Bergonzelli, G.; Waeber, G.; Aubert, J.F.; Nussberger, J.; Gavras, H.; Nicod, P.; Waeber, B. 1995: Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats Hypertension 26(5): 733-737
Ljuca, F.; Nuhbegovic, S.; Ljuca, D.; Karamehic, J.; Halilbasic, A. 2001: PI-3 kinase/AKT/PKB signal transduction pathway in kidneys mediates angiotensin II-induced hypertension Medicinski Arhiv 55(4): 189-191
Rosolová, H.; Cech, F.; Sefrna, F. 2002: Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study Vnitrni Lekarstvi 48(8): 701-706
Kondo, T.; Yoshida, K.; Yoshimura, Y.; Motohashi, M.; Tanayama, S. 1996: Disposition of the new angiotensin II receptor antagonist candesartan cilexetil in rats and dogs Arzneimittel-Forschung 46(6): 594-600
Ebisu, H.; Nishikawa, M.; Tanaka, M.; Okazoe, T.; Morizawa, Y.; Shinyama, H.; Nakamura, N. 1999: Pharmacologic profiles of GA0113, a novel quinoline derivative angiotensin II AT1-receptor antagonist Journal of Cardiovascular Pharmacology 34(4): 526-532
Delano, B.G.; Suresh, U.; Feldman, J.; Schneider, D.; Friedman, E.A. 2000: Dismal rehabilitation in predominantly type II diabetics on dialysis in Inner-City Brooklyn Clinical Nephrology 54(2): 94-104